110404 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae; Human Immunodeficiency Virus, HIV; Use of virus, viral particle or viral elements as a vector Special targeting system for viral vectors
ADAPTER-BASED RETROVIRAL VECTOR SYSTEM FOR THE SELECTIVE TRANSDUCTION OF TARGET CELLS
#2DELIVERY OF HETEROLOGOUS PROTEINS
#3PSEUDOTYPED LENTIVIRAL VECTORS
#4Novel HIV-1 Variants And Their Methods Of Use In An Animal Challenge Model
#5VIRAL PARTICLES WITH MEMBRANE-BOUND HYALURONIDASE
#6ENGINEERING HEMAGGLUTININ AND FUSION POLYPEPTIDES OF CANINE DISTEMPER VIRUS
#7COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#8PSEUDOTYPED PARTICLES, MODIFIED CELLS, RELATED COMPOSITIONS, AND RELATED METHODS
#9METHODS FOR SELECTIVELY MODULATING THE ACTIVITY OF DISTINCT SUBTYPES OF CELLS
#10METHODS AND COMPOSITIONS FOR THE ACTIVATION OF GAMMA-DELTA T-CELLS
#11Promoter Sequences for In Vitro and In Vivo Expression of Gene Therapy Products in CD3+ Cells
#12Polymer-Encapsulated Viral Vectors for In Vivo Genetic Therapy
#13MODIFIED HEMATOPOIETIC STEM/PROGENITOR AND NON-T EFFECTOR CELLS, AND USES THEREOF
#14MULTICISTRONIC VECTOR FOR SURFACE ENGINEERING LENTIVIRAL PARTICLES
#15ADAPTER-BASED RETROVIRAL VECTOR SYSTEM FOR THE SELECTIVE TRANSDUCTION OF TARGET CELLS
#16Methods and compositions for the activation of gamma-delta T-cells
#17Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#18Polymer-Encapsulated Viral Vectors for Genetic Therapy
#19Nucleic acid application primers
#20Methods and compositions for the activation of gamma-delta T-cells
#21Nipah virus envelope glycoprotein pseudotyped lentivirus
#22Methods and compositions for the activation of gamma-delta T-cells
#23Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#24LENTIVIRAL VECTORS AND USES THEREOF
#25Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening
#26METHODS FOR INCREASING THE INFECTIVITY OF VIRUSES
#27Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#28Modified stem cells and uses thereof
#29COCAL ENVELOPE PSEUDOTYPED RETROVIRAL VECTOR PRODUCER CELLS
#30Cocal vesiculovirus envelope pseudotyped retroviral vectors
#31Methods and compositions relating to improved lentiviral vectors and their applications
#32Methods and compositions for transducing lymphocytes and regulated expansion thereof
#33Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#34Methods and compositions relating to improved lentiviral vectors and their applications
#35Pseudotyped lentiviral vectors
#36Methods and compositions for increasing transgene activity
#37Method of targeting gene delivery using viral vectors
#38Methods and compositions relating to improved lentiviral vectors and their applications
#39Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#40Methods for increasing the infectivity of viruses utilizing alkyne-modified fatty acids
#41Pharmaceutical composition comprising NANOG SHRNA, and method of using NANOG SHRNA to treat cancer
#42Lentiviral vectors pseudotyped with mutant BaEV glycoproteins
#43Methods and compositions relating to improved lentiviral vectors and their applications
#44Vector particles for targeting CD34+ cells
#45Targeting pseudotyped retroviral vectors
#46Neuron-specific retrograde transport vector
#47Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#48Chimeric human immunodeficiency virus type 1 (HIV-1) with enhanced dendritic cell and macrophage tropism comprising the simian immunodeficiency virus (SIV) minimal Vpx packaging domain
#49Vectors and methods for transducing B cells
#50Methods and compositions relating to improved lentiviral vectors and their applications
#51Retrograde transport viral vector system having envelope comprising fused glycoprotein
#52Targeted particles and methods of using the same
#53COCAL VESICULOVIRUS ENVELOPE PSEUDOTYPED RETROVIRAL VECTORS
#54Viral infection enhancing peptide
#55Hepatitis B virus compositions and methods of use
#56Method of targeted gene delivery using viral vectors
#57Method of transducing non-dividing myeloid cells utilizing chimeric murine leukemia viruses containing Vpx
#58MODULATION OF PRODUCTION OF RETROVIRUSES BY APOBEC4
#59NON-INTEGRATING REV-DEPENDENT LENTIVIRAL VECTOR AND METHODS OF USING THE SAME
#60Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#61Vector particles for targeting CD34+ cells
#62Pseudotyping of retroviral vectors, methods for production and use thereof for targeted gene transfer and high throughput screening
#63Targeting pseudotyped retroviral vectors
#64Muller Cell Specific Gene Therapy
#65LENTIVIRUS PSEUDOTYPED WITH INFLUENZA HEMAGGLUTININ AND METHODS OF USE
#66Lentiviral vectors allowing RNAi mediated inhibition of GFAP and vimentin expression
#67Methods of treating lysosomal storage related diseases by gene therapy
#68Methods and compositions relating to improved lentiviral vectors and their applications
#69Production of Lentiviral Vectors
#70Foamy viral envelope genes
#71MEDICAL TREATMENT DEVICE FOR TREATING AIDS BY UTILIZING MODIFIED HUMAN IMMUNODEFICIENCY VIRUS VIRIONS TO INSERT ANTI-VIRAL MEDICATIONS INTO T-HELPER CELLS
#72LENTIVIRAL VECTOR-MEDIATED GENE TRANSFER AND USES THEREOF
#73Method and means for producing high titer, safe, recombinant lentivirus vectors
#74Targeting Pseudotyped Retroviral Vectors
#75Lentiviral vectors for site-specific gene insertion
#76Non-integrative and non-replicative lentivirus, preparation and uses thereof
#77TRANSIENTLY IMMORTALIZED CELLS FOR USE IN GENE THERAPY
#78Method for expression of small antiviral RNA molecules with reduced cytotoxicity within a cell
#79Method of treating arthritis using lentiviral vectors in gene therapy
#80Chimaeric vector system
#81Lentiviral apoe2 gene therapy
#82Method of targeted gene delivery using viral vectors
#83Transduction vector based on modified HIV-2
#84Retroviral delivery system
#85Lentiviral vector-mediated gene transfer and uses thereof
#86Methods of treating lysosomal storage related diseases by gene therapy
#87Lentiviral vectors and uses thereof
#88Lentiviral vectors for site-specific gene insertion
#89Chimeric ebola virus envelopes and uses therefor
#90Single cell analysis of HIV replication capacity and drug resistance
#91Development of a murine model of HIV-1 infection on the basis of construction of EcoHIV, a chimeric, molecular clone of human immunodeficiency virus type 1 and ecotropic moloney murine leukemia virus competent to infect murine cells and mice
#92Lentiviral vectors derived from SIVsmm/PBj14, method for their production and uses thereof
#93Method of transducing ES cells
#94Targeted particles and methods of using the same
#95Compositions and methods for tissue specific targeting of lentivirus vectors
#96Pseudotyped lentiviral vectors and uses thereof